Visualizar Tese - Instituto de Biociências - Unesp

Cirilo, PDRREFERÊNCIAS215Hakki T and Bernhardt R. CYP17- and CYP11B-dependent steroid hydroxylases as drugdevelopment targets. Pharmacol Ther, 111, 27-52, 2006.Han JH, Lee S, Park YS et al. IFITM6 expression is increased in macrophages of tumor-bearing mice.Oncol Rep, 25, 531-536, 2011.Harrison-Woolrych ML, Sharkey AM, Charnock-Jones DS et al. Localization and quantification ofvascular endothelial growth factor messenger ribonucleic acid in human myometrium andleiomyomata. J Clin Endocrinol Metab, 80, 1853-1858, 1995.Hastings PJ, Lupski JR, Rosenberg SM et al. Mechanisms of change in gene copy number. Nat RevGenet, 10, 551-564, 2009.Heim S, Nilbert M, Vanni et al. A specific translocation, t (12;14) (q14–15;q23–24), characterizes asubgroup of uterine leiomyomas. Cancer Genet Cytogenet, 32, 13–17, 1988.Heinrich UR, Brieger J, Gosepath J et al. Frequent chromosomal gains in recurrent juvenilenasopharyngeal angiofibroma. Cancer Genet Cytogene, 175, 138-143, 2007.Heinzen EL, Yoon W, Tate SK et al. Nova2 interacts with a cis-acting polymorphism to influence theproportions of drug-responsive splice variants of SCN1A. Am J Hum Genet, 80, 876-883,2007.Hennig Y, Deichert U, Bonk U et al. Chromosomal translocations affecting 12q14-15 but notdeletions of the long arm of chromosome 7 associated with a growth advantage of uterinesmooth muscle cells. Mol Hum Reprod, 5, 1150-1154, 1999.Hess JL. Chromosomes translocation in benign tumors: the HMGI proteins. Am J Clin Pathol, 109,251–261, 1998.Hirsch HA, Iliopoulos D, Joshi A et al. A transcriptional signature and common gene networks linkcancer with lipid metabolism and diverse human diseases. Cancer Cell, 17, 348–361, 2010.Hodge JC and Morton CC. Genetic heterogeneity among uterine leiomyomata: insights intomalignant progression. Hum Mol Genet, 16, R7–R13, 2007.Hodge JC, Quade BJ, Rubin MA et al. Molecular and cytogenetic characterization of plexiformleiomyomata provide further evidence for genetic heterogeneity underlying uterine fibroids.Am J Pathol, 172, 1403-1410, 2008.Hodge JC, Park PJ, Dreyfuss JM et al. Identifying the molecular signature of the interstitial deletion7q subgroup of uterine leiomyomata using a paired analysis. Genes Chromosomes Cancer,48, 865–885, 2009.Hoeijmakers JHJ. Genome maintenance mechanisms for preventing cancer. Nature, 411, 366-374,2001.Hoffman PJ, Milliken DB, Gregg LC et al. Molecular characterization of uterine fibroids and itsimplication for underlying mechanisms of pathogenesis. Fertil Steril, 636-649, 2004.